APA (7th ed.) Citation

Puckrin, R., Villa, D., Fleury, I., Larouche, J., & Kuruvilla, J. (2026). First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma. Current Oncology, 33(7), 426. https://doi.org/10.3390/curroncol33070426

Chicago Style (17th ed.) Citation

Puckrin, Robert, Diego Villa, Isabelle Fleury, Jean-François Larouche, and John Kuruvilla. "First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma." Current Oncology 33, no. 7 (2026): 426. https://doi.org/10.3390/curroncol33070426.

MLA (9th ed.) Citation

Puckrin, Robert, et al. "First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma." Current Oncology, vol. 33, no. 7, 2026, p. 426, https://doi.org/10.3390/curroncol33070426.